David W Hammers Selected Research

David W Hammers Research Topics

4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 05/2024 - 01/2016
4	Ischemia 04/2015 - 10/2008
3	Muscular Dystrophies (Muscular Dystrophy) 10/2019 - 01/2016
2	Neoplasms (Cancer) 02/2023 - 01/2023
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023 - 01/2023
2	Fibrosis (Cirrhosis) 10/2022 - 01/2020
1	Disease Progression 10/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Hypertrophy 10/2019
1	Muscle Weakness 10/2019
1	Fatigue 01/2019
1	Sarcoglycanopathies 01/2019
1	Wasting Syndrome (Wasting Disease) 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2016
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2016
1	Reperfusion Injury 11/2015

4	Insulin-Like Growth Factor I (IGF-1)IBA 10/2019 - 04/2011
3	DystrophinIBA 05/2024 - 01/2016
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2023 - 01/2023
1	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2022
1	prednylidene (Pred)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Insulin-Like PeptidesIBA 10/2019
1	DysferlinIBA 10/2019
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	edasalonexentIBA 12/2016
1	TRPC6 Cation ChannelIBA 01/2016
1	Tadalafil (Cialis)FDA Link 01/2016
1	Threonine (L-Threonine)FDA Link 01/2016
1	CalpainIBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	m-calpainIBA 01/2016
1	activin receptor type II-BIBA 01/2016
1	UtrophinIBA 01/2016
1	Phosphodiesterase 5 InhibitorsIBA 01/2016
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2016
1	Chemokine CXCL12IBA 11/2015